ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Baltimore, MD, USA:

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (SUNRISE)

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

Baltimore, Maryland, United States and 22 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Baltimore, Maryland, United States and 24 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Baltimore, Maryland, United States and 35 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Takoma Park, Maryland, United States and 55 other locations

double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Nonalcoholic Steatohepatitis (NASH)
Drug: Placebo
Drug: HTD1801

Phase 2

HighTide Therapeutics

Baltimore, Maryland, United States of America and 54 other locations

with type 2 diabetes (T2D)....

Enrolling
Type 2 Diabetes
Other: Facilitated referral to a cardiometabolic team-based center
Other: Decision support
American College of Cardiology

Washington, District of Columbia, United States

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Baltimore, Maryland, United States and 59 other locations

(SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every ...

Enrolling
Type 1 Diabetes
Behavioral: SMA visits
Children's National
Children's National

Washington, District of Columbia, United States

Phase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic...

Enrolling
Diabetic Foot Ulcer
Device: Transforming Powder Dressing
Other: Standard of care topical wound agents and dressings
ULURU Inc.

Baltimore, Maryland, United States and 11 other locations

The study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic...

Enrolling
Diabetic Foot
Diabetic Foot Ulcer
Device: Symphony™ plus Off-loading
Device: Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery

York, Pennsylvania, United States of America and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems